Morin Jean-François, Daneault Jean-Gabriel, Krebs Marie-Odile, Shah Jai, Solida-Tozzi Alessandra
Clinique pour jeunes adultes ayant eu un épisode psychotique (JAP), Centre hospitalier de l'Université de Montréal ; Département de psychiatrie et d'addictologie, Université de Montréal.
Clinique Jean-Pierre Mottard ; Programme des premiers épisodes psychotiques, Hôpital en santé mentale Albert-Prévost, CIUSSS du Nord-de-l'Île-de-Montréal ; Département de psychiatrie et d'addictologie, Université de Montréal.
Sante Ment Que. 2021 Fall;46(2):85-112.
Objectives This article aims to contextualize and review interventions for patients with a clinical high-risk (CHR) state for psychosis. Method This review explores the literature on the CHR state and focuses more precisely on the development of its defining criteria, the evolution of CHR patients, the main interventions studied so far, and the clinical services implemented to date. Results The CHR criteria were developed from observations on the prodrome of psychotic disorders to prevent or delay the onset of psychosis. These criteria help defining three distinct groups of patients who seek help because of significant distress and functional impairments. The diagnostic evaluation remains a critical step that represents a challenge for clinicians. A significant proportion of CHR patients will not develop a psychotic disorder. And the course can be unfavorable even if there is no conversion to a psychotic disorder. In order to improve the clinical conditions of CHR patients, several interventions have been developed and studied. They fall into two main categories: psychosocial approaches and pharmacotherapy. Clinical initiatives to assess and provide support to these patients have emerged around the world, including in Switzerland, in France, and in Canada. The implementation and the integration of these services within existing health care system are influenced by several factors, including the organization of health care structures. Knowing that only a small proportion of CHR patients will progress to a psychotic disorder, it is relevant to offer these interventions in non-stigmatizing and youth-friendly places. These services would possibly be distinct from first-episode psychosis programs. Conclusion Interventions for CHR patients go well beyond the prevention of psychosis. They meet legitimate clinical needs. We must think about how to deploy them adequately in the most appropriate places.
目标 本文旨在将针对临床高危(CHR)精神病状态患者的干预措施置于具体情境中并进行综述。方法 本综述探讨了关于CHR状态的文献,并更精确地聚焦于其定义标准的发展、CHR患者的演变、迄今为止研究的主要干预措施以及迄今实施的临床服务。结果 CHR标准是从对精神障碍前驱期的观察中发展而来,以预防或延迟精神病的发作。这些标准有助于界定三组不同的患者,他们因严重痛苦和功能损害而寻求帮助。诊断评估仍然是关键步骤,对临床医生来说是一项挑战。相当一部分CHR患者不会发展为精神障碍。即使没有转变为精神障碍,病程也可能不利。为了改善CHR患者的临床状况,已经开发并研究了几种干预措施。它们主要分为两类:心理社会方法和药物治疗。世界各地都出现了评估和支持这些患者的临床举措,包括在瑞士、法国和加拿大。这些服务在现有医疗保健系统中的实施和整合受到多种因素影响,包括医疗保健结构的组织。鉴于只有一小部分CHR患者会发展为精神障碍,在无歧视且对年轻人友好的场所提供这些干预措施是有意义的。这些服务可能与首发精神病项目不同。结论 针对CHR患者的干预措施远远超出了预防精神病的范畴。它们满足了合理的临床需求。我们必须思考如何在最合适的场所充分部署这些措施。